one8zero8 LLC bought a new position in Revvity Inc. (NYSE:RVTY – Free Report) during the second quarter, according to its most recent filing with the SEC. The firm bought 10,900 shares of the company’s stock, valued at approximately $1,213,000.
Several other hedge funds have also bought and sold shares of the business. Corient Private Wealth LLC grew its holdings in shares of Revvity by 985.0% during the fourth quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock valued at $12,245,000 after buying an additional 114,903 shares during the last quarter. California State Teachers Retirement System raised its holdings in shares of Revvity by 19.8% in the 1st quarter. California State Teachers Retirement System now owns 133,809 shares of the company’s stock worth $11,723,000 after acquiring an additional 22,075 shares during the last quarter. Diamond Hill Capital Management Inc. raised its holdings in shares of Revvity by 6.3% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock worth $41,302,000 after acquiring an additional 25,233 shares during the last quarter. Bank of America Corp DE lifted its position in Revvity by 14.7% in the 1st quarter. Bank of America Corp DE now owns 880,503 shares of the company’s stock valued at $77,141,000 after acquiring an additional 112,928 shares in the last quarter. Finally, Catalyst Funds Management Pty Ltd bought a new position in Revvity in the 4th quarter valued at about $1,596,000. Institutional investors and hedge funds own 86.65% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts have commented on the company. Stifel Nicolaus decreased their price objective on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a report on Wednesday, May 6th. Zacks Research upgraded Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Weiss Ratings raised Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 30th. Barclays upped their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Finally, TD Cowen reissued a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Revvity presently has a consensus rating of “Hold” and an average price target of $108.36.
Revvity Price Performance
Revvity stock opened at $119.33 on Thursday. Revvity Inc. has a 52 week low of $81.22 and a 52 week high of $122.11. The company’s 50 day moving average price is $110.49 and its two-hundred day moving average price is $100.09. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The stock has a market cap of $13.32 billion, a P/E ratio of 56.82, a P/E/G ratio of 2.07 and a beta of 1.07.
Revvity (NYSE:RVTY – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.20. The company had revenue of $729.69 million during the quarter, compared to analyst estimates of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.Revvity’s quarterly revenue was down 1.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, equities analysts predict that Revvity Inc. will post 5.36 earnings per share for the current year.
Revvity Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio is 13.33%.
Revvity Company Profile
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Further Reading
- Five stocks we like better than Revvity
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
